NG
IBB icon

Northstar Group’s iShares Biotechnology ETF IBB Stock Holding History

Northstar Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,118
Closed -$280K – 155
2024
Q4 		$280K Sell
2,118
-100
-5% -$14.1K 0.05% 124
2024
Q3 		$323K Sell
2,218
-100
-4% -$14.5K 0.06% 120
2024
Q2 		$318K Sell
2,318
-653
-22% -$87.2K 0.06% 116
2024
Q1 		$408K Hold
2,971
– – 0.08% 100
2023
Q4 		$404K Sell
2,971
-98
-3% -$12K 0.09% 96
2023
Q3 		$375K Sell
3,069
-344
-10% -$43.7K 0.09% 100
2023
Q2 		$433K Buy
3,413
+44
+1% +$5.72K 0.1% 93
2023
Q1 		$435K Sell
3,369
-200
-6% -$26.2K 0.11% 91
2022
Q4 		$469K Sell
3,569
-401
-10% -$51.8K 0.13% 87
2022
Q3 		$465K Buy
3,970
+15
+0.4% +$1.86K 0.14% 86
2022
Q2 		$465K Sell
3,955
-150
-4% -$17.8K 0.13% 90
2022
Q1 		$535K Sell
4,105
-200
-5% -$26.1K 0.13% 93
2021
Q4 		$657K Buy
4,305
+100
+2% +$15.5K 0.16% 84
2021
Q3 		$680K Hold
4,205
– – 0.18% 83
2021
Q2 		$688K Sell
4,205
-200
-5% -$30.8K 0.18% 83
2021
Q1 		$663K Buy
4,405
+1
+0% +$159 0.19% 81
2020
Q4 		$667K Sell
4,404
-100
-2% -$14.3K 0.2% 78
2020
Q3 		$610K Sell
4,504
-99
-2% -$13.4K 0.21% 79
2020
Q2 		$629K Sell
4,603
-601
-12% -$76.6K 0.25% 70
2020
Q1 		$561K Sell
5,204
-339
-6% -$39K 0.26% 70
2019
Q4 		$668K Sell
5,543
-400
-7% -$44.6K 0.26% 73
2019
Q3 		$591K Sell
5,943
-20
-0.3% -$2.09K 0.25% 73
2019
Q2 		$651K Sell
5,963
-1,279
-18% -$136K 0.28% 73
2019
Q1 		$810K Buy
7,242
+180
+3% +$19.7K 0.36% 67
2018
Q4 		$662K Sell
7,062
-1,321
-16% -$140K 0.34% 66
2018
Q3 		$1.02M Sell
8,383
-297
-3% -$35K 0.47% 53
2018
Q2 		$920K Buy
8,680
+450
+5% +$48.1K 0.47% 56
2018
Q1 		$878K Buy
+8,230
New +$912K 0.46% 55

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Northstar Group's IBB Position: Q1 2025 in Review

Northstar Group sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 2,118 shares — an estimated $280K sold.

Northstar Group first reported a position in IBB in Q1 2018 and held it in 28 quarters. The position peaked at $1.02M in Q3 2018. 832 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Northstar Group reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Northstar Group sold 2,118 iShares Biotechnology ETF shares in Q1 2025, an estimated $280K.
  • Northstar Group first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 28 quarters.
  • Northstar Group's iShares Biotechnology ETF position peaked at $1.02M in Q3 2018.
  • 832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Northstar Group's 13F filing for Q1 2025, filed 17 Apr 2025.